All News

Leading political outlets report today that shifts in public opinion on the Affordable Care Act (ACA), or at least its components, have led US Senate campaigns to adjust ads accordingly, most notably in Arkansas. However, the changes in tone toward the ACA, often called "Obamacare," may not change the outcome of the 2014 mid-term elections, according to published reports.

An employee of the Wisconsin-based Orion Energy Systems Inc. was first fined and then fired for her refusal to participate in the company's wellness program.

Insurers are trapped between pharmaceutical companies developing increasingly expensive drug treatments, and states that want to reduce the patient-burden of co-pays. Additionally, states like New York and Alaska have banned payers from using specialty formularies.

The cost regulator for the NHS in England and Wales has said that Celgene's Revlimid should be an option for treating patients with a particular form of myelodysplastic syndromes.

In light of the recent hacking event at Community Health Systems. Aetna's Chief Information Security Officer discusses measure being implemented to improve security on their end.

Combining nab-paclitaxel with nivolumab is expected to have a synergistic effect in the various tumor types to be targeted, while providing Celgene access to the immunooncology race.

A century ago, employee health and well-being was of such little concern to most US employers that it took the passage of workers' compensation laws for most to care, because suddenly it affected the bottom line.

The trials will evaluate the efficacy of erlotinib or crizotinib in preventing lung cancer recurrence, as well as survival, in patients carrying mutations in either EGFR or ALK, who are clinically free of the disease.

The mid-stage trial was conducted in a small group of patients, but further studies will roll-out soon.

Guidelines, such as those developed by the Children's Oncology Group, can prove a useful resource to monitor and/or treat adults who have previously been treated for a pediatric cancer.

The two studies, published in the August issue of JAMA Internal Medicine, examine the pros and cons of the current cancer screening methodologies.

The study, published in the journal Health Service Research, found that the timing of the financial incentives offered by the program was not associated with improved quality of care.

Reports that information on 4.5 million patients from 26 states had been hacked from more than 200 hospitals stunned consumers and the health care community yesterday, even though experts in health information technology have warned of this possibility for some time. News of the hacking incident within Community Health Systems comes as the top US official charged with overseeing the nation's health information technology (HIT) is trying to educate patients about what to expect about the use of their healthcare information.

The study identified that there are no set methods to determine cost for a particular test.

The writer asks: is more information better, even if we don't understand what it means?

The study, published in the British Journal of Cancer, observed poor survival at the end of the follow-up period in men carrying the mutation, compared to non-carriers.

The analysis recommends conducting the PSA test in those less than 70 years of age, to avoid overdiagnosis while reducing death by at least 50%.

This year has brought growing awareness about needs in mental health, including the need to learn more about the genetic underpinnings of the disease. Today, investigators supported by the National Institutes of Health announced a major step forward toward that goal. Reporting in the journal Nature, the group said it had shown how a rate mutation in a suspicious gene sets off a chain reaction in other genes, disrupting the synapses, which function like a switch between neural connections.

A new Kaiser Family Foundation report analyzes key trends that have shaped the Medicare Part D marketplace since the program launched nine years ago, providing a detailed assessment of changes in plan availability, enrollment, premiums and cost sharing in both private stand-alone drug plans, and Medicare Advantage drug plans.

People who bought state plans instead of seeking insurance through their employer, have to go through the process again due to a temporary fix that was afforded.